cGxP.wire https://validator.w3.org/feed/docs/rss2.html HUTCHMED and AstraZeneca Submit US NDA for ORPATHYS Plus TAGRISSO REGENXBIO Reports Three-Year Data for Surabgene in Retinopathy Immuneering Presents Atebimetinib Pancreatic Cancer Data at AACR Castle Biosciences Study Supports Molecular Guidance in AD Henlius Partners With Amberstone on Next-Gen TCEs CervoMed Advances Neflamapimod With New Tablet and FDA Dose Flexibility Pfizer to Present 45 Oncology Abstracts at ESMO 2026 AN2 Therapeutics Extends GSK Tuberculosis Research Collaboration Leads Biolabs Gains Japan Orphan Drug Designation for Opamtistomig Codexis Partners With siRNA Innovator on Stereo-Defined Synthesis Atavistik Bio Partners With Roche on Allosteric Drug Discovery Eton Launches U.S. Commercial Availability of IMPAVIDO Glycomine Gains FDA Breakthrough Status for GLM101 Tiziana Doses First Participants in ALS Foralumab Trial Boehringer Ingelheim and WHO Foundation Expand Obesity Care Sagimet to Present 52-Week Denifanstat Data at KOL Event WuXi Biologics Passes FDA GMP Inspection at Wuxi Site 4basebio and TriLink Advance Phase I Cell Therapy Program Clywedog Therapeutics Reports Phase 1b Balomenib Results Moleculin Reports Cardiac Safety Data for Annamycin Arvinas Doses First Patient in ARV-6723 Phase 1/2 Trial Veeva Systems Launches AI Agent for Clinical Study Builds MediciNova Reports Phase 2 MN-001 Results in Metabolic Disease Atossa Therapeutics Joins ARDD 2026 Clinical Trials Panel QIAGEN Gains FDA Clearance for QIAstat-Dx Bloodstream Panel Marani Health Wins FDA Clearance for M•care System Aqua Medical Secures Series B to Advance Diabetes Trial Synergy Spine Solutions Reports Two-Year Synergy Disc Results Lakewood-Amedex Starts Phase 2a Trial of Nu-3 for Foot Ulcers Eli Lilly Wins FDA Approval for Once-Weekly Onswik Insulin DelveInsight Highlights Myotonic Dystrophy Market Growth Through 2036 Theranica Reports 91% Precision in AI Migraine Forecasting Study Avabello Aesthetics Founder Joins 2026 IAFA Aesthetic Symposium Lupus Research Alliance Awards $450K to Advance Lupus Therapies Oracle Expands Life Sciences Data Intelligence With AI and RWD ViferaXS Raises €12M to Advance CLL Phase II Trial Johnson & Johnson Reports TREMFYA Axial PsA Study Data Pharming Gains FDA Priority Review for Lower-Dose Joenja ITM Reports Re-treatment and Dosimetry Data for 177Lu-Edotreotide Tempo Therapeutics Wins $2.25M NIH Grant for Wound Healing HUTCHMED Initiates Global Phase I Trial of HMPL-A830 Flen Health and AGC Biologics Advance Enzyme Wound Therapy Alume Biosciences Gains FDA Breakthrough Therapy Designation for Bevonescein Johnson & Johnson Unveils Next-Gen Trauma Innovations at OTA 2026 BMS Reports EXCALIBER-RRMM Results for ZENBEXUS AustinPx Gains FDA AMT Designation for KinetiSol Technology Zymeworks Completes $929M Theravance Biopharma Acquisition Adaptive Highlights MRD Testing in New Myeloma Cure Definition Newron Expands ENIGMA-TRS 2 Enrollment Outside U.S. Nanoscope Advances Optogenetic Therapy for Retinal Diseases